Latest Us Market News

Advanced Health Intelligence Ltd has secured up to AUD 5.5 million from Oakley Capital Partners to support its ASX reinstatement and global expansion, while targeting an additional USD 6 million and unlocking $3 million in R&D grants.

Resolution Minerals has expanded its critical minerals footprint with the acquisition of the Horse Heaven Project in Idaho, complementing its Australian assets and setting the stage for a NASDAQ listing.

Ovanti Limited has appointed Peter Maher, a seasoned BNPL executive from Zip Co, to lead its US expansion, while exploring a NASDAQ listing via dual-listing or SPAC merger and reconsidering the sale of a key dividend-yielding asset.

4DMedical has landed a $10 million strategic investment from Pro Medicus, aimed at accelerating its commercial growth and advancing its CT – VQ™ technology towards FDA clearance in the US.

BirdDog Technology Limited reported a 6.9% increase in quarterly sales to A$4.3 million, driven by the successful launch of two next-generation broadcast products and a strong cash position ahead of a planned share buy-back.

IRIS Metals has successfully completed test mining at its fully permitted Beecher lithium project and expanded its US footprint with a strategic acquisition, while securing $4.27 million to fund ongoing exploration and development.

Optiscan Imaging Ltd has launched its first in-human breast cancer study and unveiled a new veterinary imaging device, while securing a key US collaboration to support FDA submissions.

Pure Hydrogen reports a second consecutive quarter of positive cash flow, expands its international hydrogen vehicle footprint, and secures a 15-year gas project permit in Queensland.

Tasman Resources progresses exploration at Lake Torrens and Parkinson Dam projects while managing capital through a recent entitlement offer and loan repayments.

Clarity Pharmaceuticals has bolstered its cash reserves to approximately $288 million following a $203 million institutional placement, while reporting significant clinical progress across multiple copper-based radiopharmaceutical trials targeting prostate cancer and neuroendocrine tumours.

Eden Innovations reports a striking 114% year-on-year jump in Q4 US sales of its EdenCrete® products, alongside a 50% annual sales increase and significant debt reduction plans.

Cettire warns that recent US tariff changes removing duty-free exemptions on shipments under $800 could impact nearly half its revenue. The luxury e-commerce platform is evaluating the consequences and adjusting its global strategy.